Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Simone C. Tazoll"'
Autor:
James J. Phelan, Sharee A. Basdeo, Simone C. Tazoll, Sadhbh McGivern, Judit R. Saborido, Joseph Keane
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Tuberculosis (TB) is the world's biggest infectious disease killer. The increasing prevalence of multidrug-resistant and extensively drug-resistant TB demonstrates that current treatments are inadequate and there is an urgent need for novel therapies
Externí odkaz:
https://doaj.org/article/19275a69735a4e169bae82f977099ac3
Autor:
Lara Linnemann, Andreas Kispert, Michael Leitges, Martina Hein, Tim Vierbuchen, Annette S. Gross, Alexandra Hölscher, Christoph Lange, Franziska Waldow, Dominik Schwudke, Julius Brandenburg, Christoph Hölscher, Ulrich E. Schaible, Holger Heine, Jan Rupp, Barbara Kalsdorf, Thomas Scholzen, Simone C. Tazoll, Norbert Reiling, Jochen Behrends, Torsten Goldmann, Stefan Niemann, Maja Reimann, Svenja Goldenbaum, Sebastian Marwitz
Publikováno v:
J Clin Invest
In view of emerging drug-resistant tuberculosis (TB), host-directed adjunct therapies are urgently needed to improve treatment outcomes with currently available anti-TB therapies. One approach is to interfere with the formation of lipid-laden "foamy"
Autor:
Christoph Hoelscher, Franziska Waldow, Martina Hein, Jan Rupp, Julius Brandenburg, Andreas Kispert, Barbara Kalsdorf, Sebastian Marwitz, Michael Leitges, Christoph Lange, Alexandra Hoelscher, Annette S. Gross, Tim Vierbuchen, Dominik Schwudke, Simone C. Tazoll, Jochen Behrends, Norbert Reiling, Stefan Niemann, Ulrich E. Schaible, Svenja Goldenbaum, Thomas Scholzen, Holger Heine, Lara Linnemann, Torsten Goldmann, Maja Reimann
In view of emerging drug-resistant tuberculosis, host directed therapies are urgently needed to improve treatment outcomes with currently available anti-tuberculosis therapies. One option is to interfere with the formation of lipid-laden “foamy”
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c78231a70a6cef789cdbd8c113e5a23a
https://doi.org/10.1101/2020.06.26.174110
https://doi.org/10.1101/2020.06.26.174110
Autor:
Simon J. Foster, Eric J. G. Pollitt, Bartłomiej Salamaga, Alison M. Condliffe, Stephen A. Renshaw, Joe W. Gray, Grace R. Pidwill, Jacob Biboy, Oliver T. Carnell, Lucia Lafage, Joshua A. F. Sutton, William Turnbull, Simone C. Tazoll, Josie F. Gibson, Natalia H Hajdamowicz, Waldemar Vollmer
Publikováno v:
PLoS Pathogens, Vol 17, Iss 3, p e1009468 (2021)
PLoS Pathogens
PLoS Pathogens
Peptidoglycan is the major structural component of the Staphylococcus aureus cell wall, in which it maintains cellular integrity, is the interface with the host, and its synthesis is targeted by some of the most crucial antibiotics developed. Despite
Autor:
Joshua A F Sutton, Oliver T Carnell, Lucia Lafage, Joe Gray, Jacob Biboy, Josie F Gibson, Eric J G Pollitt, Simone C Tazoll, William Turnbull, Natalia H Hajdamowicz, Bartłomiej Salamaga, Grace R Pidwill, Alison M Condliffe, Stephen A Renshaw, Waldemar Vollmer, Simon J Foster
Publikováno v:
PLoS Pathogens, Vol 17, Iss 3, p e1009468 (2021)
Peptidoglycan is the major structural component of the Staphylococcus aureus cell wall, in which it maintains cellular integrity, is the interface with the host, and its synthesis is targeted by some of the most crucial antibiotics developed. Despite
Externí odkaz:
https://doaj.org/article/fcebc94d5e2540bd8ac9e1aa6695335c